$XENE SEC Filings

Filed On	Filing
16 Oct 2026	Form 4: Kelly Thomas Patrick, Chief Financial Officer Received 7,500 shares by exercise or conversion
01 Oct 2026	Form 4: Kelly Thomas Patrick, Chief Financial Officer Bought 15,000 shares ($560K)
01 Oct 2026	Form 4: Mortimer Ian, Director Bought 30,000 shares ($1.12M)
03 Sep 2026	Form 4: Svoronos Dawn, Director Received 5,144 shares by exercise or conversion ($41.9K)
31 Aug 2026	Form 4: Kenney Christopher John, Chief Medical Officer Sold 7,068 shares ($426K)
28 Aug 2026	144
13 Aug 2026	Form 4: Gannon Steven, Director Sold 10,000 shares ($641K)
13 Aug 2026	144
13 Aug 2026	SCHEDULE 13G/A
07 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
08 Jun 2026	Form 4: Patou Gary, Director Sold 1,322 shares ($70.3K)
08 Jun 2026	Form 4: Cannon Gillian, Director Sold 1,190 shares ($63.2K)
05 Jun 2026	144
05 Jun 2026	144
03 Jun 2026	Form 4: Patou Gary, Director Received 2,645 shares by exercise or conversion · Granted 10,507 Share Option (Right to Buy) · Granted 1,593 Restricted Share Units
03 Jun 2026	Form 4: Machado Patrick, Director Received 2,645 shares by exercise or conversion · Granted 10,507 Share Option (Right to Buy) · Granted 1,593 Restricted Share Units
03 Jun 2026	Form 4: Gover Justin D., Director Received 2,645 shares by exercise or conversion · Granted 10,507 Share Option (Right to Buy) · Granted 1,593 Restricted Share Units

Comments